chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Musculoskeletal discomfort, Myalgia
Clinical narrative: muscle pain in the lower legs area; discomfort in  joints; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 04Apr2021 at 09:15 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient did not have allergies to medications, food, or other products. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021 at 14:00 the patient experienced muscle pain in the lower legs area and discomfort in joints. After 24 hours of the first dose,  the patient presented muscle pain in the lower legs area and discomfort in the joints - ankle area. The symptoms were noticeable by the end of the Sunday ( >30 hours) after the administration. The patient did not receive any treatment for the reported adverse events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event muscle pain in the lower legs area and discomfort in joints was recovered on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: rash on chest and breast area; This is a spontaneous report from a contactable consumer, the patient. A 24-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the left arm on 02Apr2021 at 13:00 (at the age of 24-years-old) as a single dose for COVID-19 immunisation. Medical history was not provided. The patient did not have any allergies to food, medications, or other products. Concomitant medications included spironolactone (MANUFACTURER UNKNOWN) , curcuma longa (TURMERIC), glucosamine (MANUFACTURER UNKNOWN), collagen (MANUFACTURER UNKNOWN) all from an unknown date and for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks, prior to the vaccination. On 04Apr2021 at 19:00, two days after receiving the vaccine the patient experienced rash on chest and breast area. The patient did not have any changes to her diet or medication in the past month, saved for the COVID Vaccine. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported adverse event. The clinical outcome of the event rash on chest and breast area was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Got shingles two weeks after the first dose; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 12Mar2021 at 16:00(at the age of 50-year-old) as a single dose for COVID-19 immunisation. Medical history included graves' disease and shingles. Concomitant medications included alprazolam (MANUFACTURER UNKNOWN) and levothyroxine sodium(SYNTHOID), all from unknown date for unknown indication. The patient previously took erythromycin(MANUFACTURER UNKNOWN) and experienced allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On an unknown date in 2021 two weeks after the first dose, the patient experienced shingles. The patient reported that she already had shingles a few years ago so this was her second time getting them and it was not severe but a small patch on her stomach and back. The patient received treatment(unspecified medication) for the reported event. The adverse event  resulted in a visit to the doctors or other healthcare professional office/clinic visit. The clinical outcome of the event shingles was recovered on an unknown date in 2021.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Fatigue, Pyrexia
Clinical narrative: Fever began about 6 hrs and lasted for about 48 hours. Temperature reached 102.6.; Followed by a couple days of exhaustion.; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the arm left on 31Mar2021 at 14:30 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not receive any concomitant medications. The patient previously took penicillin (MANUFACTURER UNKNOWN) and experienced allergy on an unknown date. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER6207) via an unspecified route of administration in the arm left on 10Mar2021 at 14:30 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021 at 21:30, the patient experienced fever began about 6 hrs and lasted for about 48 hours. Temperature reached 102.6, followed by a couple days of exhaustion. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events fever and exhaustion was recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Ringing in left ear; This is a spontaneous report from a non-contactable consumer, the patient. A 32-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the left arm on 05Apr2021 at 14:30 (at the age of 32-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. On 05Apr2021 at 15:00, the patient experienced ringing in left ear. The event did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of the event ringing in left ear was not recovered.   No follow-up attempts are needed. No further information is expected.
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: Vitiligo
Clinical narrative: Started to see a white spot on my neck; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 16Mar2021 at 17:30 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Medical history included vitiligo which stopped spreading long time back. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 20Mar2021, the patient started seeing white spot on his neck 4 days after vaccination and the patient reported that there was no change in his diet or medication prior to or after the vaccine. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported event. The clinical outcome of white spots on neck (vitiligo) was unknown at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Nausea, Pain, Pyrexia
Clinical narrative: hydrochloride (ALLEGRA) from on unknown date for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Apr2021 at 12:00, the patient had experienced fatigue, nausea, fever, soreness and headache. Adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcome of the events fatigue, nausea, fever, soreness and headache was resolved on unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Blood urine present
Clinical narrative: Threads of blood discharge during urination; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6201) via an unspecified route of administration in the arm left on 03Apr2021 at 10:30 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. Concomitant medication was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04Apr2021 at 13:00, the patient experienced threads of blood discharge during urination. It was unknown whether the patient received any treatment for the event. The clinical outcome of the event threads of blood discharge during urination was unknown.  No follow-up attempts are needed. No further information is expected.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Hot flush, Myalgia, Nausea, Oropharyngeal pain, Pain
Clinical narrative: Injection site pain; Fever; Sore muscles; Sore body; Nausea; Hot flashes; Swelling of tonsils; Throat pain; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 02Apr2021 at 15:30 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient did not receive any medications within two weeks prior to the vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 02Apr2021 at 19:45, 4 hours after the vaccination, the patient experienced injection site pain, fever, sore muscles/body, nausea, hot flashes and swelling of tonsils/throat pain. The adverse events neither resulted in doctor or other healthcare professional office/clinic visit nor emergency room/department or urgent care. The patient did not receive treatment for the reported adverse events. The clinical outcome of the events injection site pain, fever, sore muscles/body, nausea, hot flashes and swelling of tonsils/throat pain was resolved on unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Pharyngeal swelling, Pyrexia, Vaccination site pain
Clinical narrative: Injection site pain; Fever; Sore muscles; Sore body; Nausea; Hot flashes; Swelling of tonsils; Throat pain; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 02Apr2021 at 15:30 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient did not receive any medications within two weeks prior to the vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 02Apr2021 at 19:45, 4 hours after the vaccination, the patient experienced injection site pain, fever, sore muscles/body, nausea, hot flashes and swelling of tonsils/throat pain. The adverse events neither resulted in doctor or other healthcare professional office/clinic visit nor emergency room/department or urgent care. The patient did not receive treatment for the reported adverse events. The clinical outcome of the events injection site pain, fever, sore muscles/body, nausea, hot flashes and swelling of tonsils/throat pain was resolved on unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Discomfort, Headache, Hot flush, Pain in extremity
Clinical narrative: Headache; Sore arm; Feeling of heaviness in body; Severe hot flashes; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the right arm on 03Apr2021 at 10:15 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had known allergies to adhesive. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Apr2021 at 12:00, the patient experienced headache, sore arm, feeling of heaviness in body and severe hot flashes. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events headache, sore arm, feeling of heaviness in body and severe hot flashes was resolved on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Photopsia
Clinical narrative: Shooting lights in left eye; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: er8727) via an unspecified route of administration in the left arm on 04Apr2021 at 15:30 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient did not have allergies to medications, food, or other products. The patient received unspecified concomitant medications. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 05Apr2021, on the second day, the patient experienced shooting lights in the left eye. The patient reported that he had no issues on the day of the shot. The events did not result in a doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care visit. The patient did not receive any treatment for the event. The clinical outcome of the event shooting lights in left eye was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Menstruation irregular
Clinical narrative: Period came 1 week early.; This is a spontaneous report from a non-contactable consumer, the patient. A 36-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration on 31Mar2021 at 11:15 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. Medical history included anxiety and precancerous breast lump removal. Concomitant medications included venlafaxine hydrochloride (EFFEXOR), ibuprofen (MANUFACTURER UNKNOWN) from an unknown date for an unspecified indication. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6198) via an unspecified route of administration on 10Mar2021 at 08:00 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Apr2021 the patient experienced period came 1 week early.  The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of irregular menstruation was unknown.   No follow-up attempts are needed. No further information is expected.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling abnormal, Vaccination site pain
Clinical narrative: Injection site pain; Tiredness; Felt fuzzy; This is a spontaneous report from a non-contactable consumer, the patient. A 32-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 05Apr2021 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medication were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 05Apr2021, the patient experienced injection site pain, tiredness and felt fuzzy. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events injection site pain, tiredness and felt fuzzy were unknown at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Swollen tongue
Clinical narrative: Swollen lymph nodes; Swollen tongue at time of administration; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: unknown) via an unspecified route of administration in the right arm on 01Apr2021 at 15:00 (at the age of 55-years-old) as a single dose for COVID-19 immunization. Medical history included allergy, asthma and bipolar. Concomitant medications included lamotrigine (LAMICTAL), amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate,  dexamfetamine sulfate (ADDERALL), clonazepam (KLONOPIN) and primidone (MANUFACTURER UNKNOWN) on an unknown dates for unknown indication. The patient previously took BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: unknown) via an unspecified route of administration in the left arm on 12Mar2021 at 14:30 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Unknown if the patient received any other vaccines within four weeks prior to the vaccination. On 01Apr2021, the patient experienced swollen tongue at the time of administration. On 03Apr2021 at 16:00 two days after vaccination, the patient experienced swollen lymph nodes. The patient did not receive any treatment for the reported events. The events did not result in doctor or other healthcare professional office or clinic and emergency room or department or urgent care. The clinical outcome of the events swollen tongue and swollen lymph nodes were not recovered at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea, Fatigue, Headache, Malaise, Nausea
Clinical narrative: Watery diarrhea; Fatigue; Malaise; Nausea; Vomiting; Arm soreness; Headache; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm right on 03Apr2021 at 08:30 (at the age of 33-year-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19 on 21Dec2020, hypertension (HTN) and hyperlipidemia. The patient did not have allergies to medications, food, or other products. Concomitant medications were not reported. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination On 04Apr2021 at 08:00, the patient experienced watery diarrhea, fatigue, malaise, nausea, vomiting, arm soreness and headache. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care visit. The patient did not receive any treatment for the events. The clinical outcome of the events watery diarrhea, fatigue, malaise, nausea, vomiting, arm soreness and headache was recovering at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Vomiting
Clinical narrative: Watery diarrhea; Fatigue; Malaise; Nausea; Vomiting; Arm soreness; Headache; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm right on 03Apr2021 at 08:30 (at the age of 33-year-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19 on 21Dec2020, hypertension (HTN) and hyperlipidemia. The patient did not have allergies to medications, food, or other products. Concomitant medications were not reported. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination On 04Apr2021 at 08:00, the patient experienced watery diarrhea, fatigue, malaise, nausea, vomiting, arm soreness and headache. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care visit. The patient did not receive any treatment for the events. The clinical outcome of the events watery diarrhea, fatigue, malaise, nausea, vomiting, arm soreness and headache was recovering at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Balance disorder, Chills, Headache, Nausea, Night sweats
Clinical narrative: Nauseous; Night sweats; Chills / more of the chills; Headache; Aching all over; Off balance/ head felt like it was swimming off balance; Throwing up; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 30Mar2021 at 15:30 (at the age of 60-year-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Concomitant medications included simvastatin (MANUFACTURER UNKNOWN), buspirone (MANUFACTURER UNKNOWN), bupropion (MANUFACTURER UNKNOWN) and fluoxetine (MANUFACTURER UNKNOWN) all for unknown indications from  an unknown dates. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021 at 15:00, the patient started experiencing chills and headache. By the night, the patient experienced aching all over, throwing up and off balance. On 01Apr2021, the patient experienced more of the chills, nauseous and head felt like it was swimming off balance. On an unknown date in Apr2021, the patient experienced night sweats. The patient experienced headache the whole time. The patient did not receive any treatment for the events. The clinical outcome of the events chills, headache, loss of balance, night sweats and nauseous was  resolved on an unknown date in Apr2021.The clinical outcome of the events general body pain and vomiting resolved on an unknown date in 2021.  No follow-up attempts are needed. No further information is expected.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Vomiting
Clinical narrative: Nauseous; Night sweats; Chills / more of the chills; Headache; Aching all over; Off balance/ head felt like it was swimming off balance; Throwing up; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 30Mar2021 at 15:30 (at the age of 60-year-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Concomitant medications included simvastatin (MANUFACTURER UNKNOWN), buspirone (MANUFACTURER UNKNOWN), bupropion (MANUFACTURER UNKNOWN) and fluoxetine (MANUFACTURER UNKNOWN) all for unknown indications from  an unknown dates. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021 at 15:00, the patient started experiencing chills and headache. By the night, the patient experienced aching all over, throwing up and off balance. On 01Apr2021, the patient experienced more of the chills, nauseous and head felt like it was swimming off balance. On an unknown date in Apr2021, the patient experienced night sweats. The patient experienced headache the whole time. The patient did not receive any treatment for the events. The clinical outcome of the events chills, headache, loss of balance, night sweats and nauseous was  resolved on an unknown date in Apr2021.The clinical outcome of the events general body pain and vomiting resolved on an unknown date in 2021.  No follow-up attempts are needed. No further information is expected.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Diarrhoea
Clinical narrative: Diarrhea; Abdominal cramping; This is a spontaneous report from a contactable physician. A 23-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot/batch number and expiration date not provided), via an unspecified route of administration on 29Mar2021 (at the age of 23-year-old) at single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient previously took clindamycin for wisdom tooth extraction 2 weeks prior to vaccine. On 30Mar2021, the patient experienced abdominal cramping first 24 hours after vaccination, resolved, then abdominal cramping with diarrhea started 5 days after vaccination (03Apr2021) and persisted for 3 days until today when seen in office and report made. The events resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of abdominal cramp and diarrhea included oral hydration. The outcome of abdominal cramping occurred on 30Mar2021 was recovered in 2021, then it re-occurred on 03Apr2021 and not recovered; diarrhea was not recovered. This report was reported as non-serious by reporter.  Information about lot/batch number cannot be obtained. No further information expected.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure increased, Blood pressure measurement, Chest discomfort, Dysgeusia, Fatigue
Clinical narrative: Metal taste in throat and mouth; Heart rate up and racing; Blood pressure went up; Became hot; Nose tingling; Itchy nose; Numb nose; Chest tighten; Tired; Sore legs; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 8729) via an unspecified route of administration in the left arm on 05Apr2021 at 09:00 (at the age of 50-year-old) as a single dose for COVID-19 immunisation. Medical history included allergy NOS. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021 at 09:30 the patient experienced metal taste in throat and mouth, heart rate up and racing, blood pressure went up, became hot, nose tingling, itchy nose, numb nose, chest tighten, tired and sore legs. The events resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the reported adverse events. On an unknown date, the patient underwent heart rate and blood pressure test and the result was increased. The clinical outcome of the events metal taste in throat and mouth, heart rate up and racing, blood pressure went up, became hot, nose tingling, itchy nose, numb nose, chest tighten, tired and sore legs were resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling hot, Heart rate, Heart rate increased, Hypoaesthesia, Pain in extremity
Clinical narrative: Metal taste in throat and mouth; Heart rate up and racing; Blood pressure went up; Became hot; Nose tingling; Itchy nose; Numb nose; Chest tighten; Tired; Sore legs; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 8729) via an unspecified route of administration in the left arm on 05Apr2021 at 09:00 (at the age of 50-year-old) as a single dose for COVID-19 immunisation. Medical history included allergy NOS. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021 at 09:30 the patient experienced metal taste in throat and mouth, heart rate up and racing, blood pressure went up, became hot, nose tingling, itchy nose, numb nose, chest tighten, tired and sore legs. The events resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the reported adverse events. On an unknown date, the patient underwent heart rate and blood pressure test and the result was increased. The clinical outcome of the events metal taste in throat and mouth, heart rate up and racing, blood pressure went up, became hot, nose tingling, itchy nose, numb nose, chest tighten, tired and sore legs were resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia, Pruritus
Clinical narrative: Metal taste in throat and mouth; Heart rate up and racing; Blood pressure went up; Became hot; Nose tingling; Itchy nose; Numb nose; Chest tighten; Tired; Sore legs; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 8729) via an unspecified route of administration in the left arm on 05Apr2021 at 09:00 (at the age of 50-year-old) as a single dose for COVID-19 immunisation. Medical history included allergy NOS. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021 at 09:30 the patient experienced metal taste in throat and mouth, heart rate up and racing, blood pressure went up, became hot, nose tingling, itchy nose, numb nose, chest tighten, tired and sore legs. The events resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the reported adverse events. On an unknown date, the patient underwent heart rate and blood pressure test and the result was increased. The clinical outcome of the events metal taste in throat and mouth, heart rate up and racing, blood pressure went up, became hot, nose tingling, itchy nose, numb nose, chest tighten, tired and sore legs were resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Dry skin, Headache, Heart rate increased, Lacrimation increased, Pruritus
Clinical narrative: Headache; Rapid heartbeat; Hives on face and neck; Rash on neck; Itchiness; Watery eyes; Extreme dryness on face; Sore arm at injection site; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the arm left on 27Mar2021 at 12:00 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not receive any medication within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the arm left on 05Mar2021 at 14:45 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. The patient was not allergic to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 27Mar2021 at 15:30, the patient experienced headache, rapid heartbeat, hives on face and neck, rash on neck, itchiness, watery eyes, extreme dryness on face and sore arm at injection site. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events headache, rapid heartbeat, hives on face and neck, rash on neck, itchiness, watery eyes, extreme dryness on face and sore arm at injection site were not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Urticaria, Vaccination site pain
Clinical narrative: Headache; Rapid heartbeat; Hives on face and neck; Rash on neck; Itchiness; Watery eyes; Extreme dryness on face; Sore arm at injection site; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the arm left on 27Mar2021 at 12:00 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not receive any medication within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the arm left on 05Mar2021 at 14:45 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. The patient was not allergic to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 27Mar2021 at 15:30, the patient experienced headache, rapid heartbeat, hives on face and neck, rash on neck, itchiness, watery eyes, extreme dryness on face and sore arm at injection site. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events headache, rapid heartbeat, hives on face and neck, rash on neck, itchiness, watery eyes, extreme dryness on face and sore arm at injection site were not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: Feeling dizzy; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Er8727) via an unspecified route of administration in the left arm on 22Mar2021 at 15:15 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. Medical history included pre-diabetic. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 22Mar2021 at 17:30, the patient experienced feeling dizzy. The patient did not receive any treatment for the event. The patient was feeling dizzy after an hour took a nap and felt better after. The clinical outcome of the event feeling dizzy was recovered on an unknown date in 2021.  No follow-up attempts are needed. No further information is expected.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Menstruation irregular, SARS-CoV-2 test
Clinical narrative: Period came two days early.; This is a spontaneous report received from a non-contactable consumer, the patient. A 23-years-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6201), via an unspecified route of administration in the left arm on 30Mar2021, as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medication included TRI SPRINTEC for unknown indication from unknown dates. The patient had not received any other vaccines within 4 weeks prior to COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19.Since the vaccination the patient has been tested for COVID-19.  On 05Apr2021, the patient underwent COVID-19 test and the result found to be negative. On 05Apr2021, the patient had irregular menstruation. It was reported that period came two days early despite birth control keeping period on same schedule for last 6 years. The clinical outcome of irregular menstruation was unknown at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Binge eating, Dyspnoea, SARS-CoV-2 test
Clinical narrative: Heavy breathing; Binge eating sugary foods; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on an unknown date at 13:00 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Patient also received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Patient had no known allergies. Concomitant medications included gabapentin (MANUFACTURER UNKNOWN) and birth control (MANUFACTURER UNKNOWN) from an unknown date for an unspecified indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 21Mar2021 at 16:00 the patient experienced heavy breathing, binge eating sugary foods within 6 hours after both the first vaccination and second vaccination. Patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. On 30Mar2021, the patient underwent color (covid test type post vaccination was nasal swab) and the result was negative. The clinical outcome of the events heavy breathing and binge eating sugary foods was recovering at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site urticaria
Clinical narrative: 1.5 inch round raised welt at the injection site; This is a spontaneous report from a contactable consumer, the patient. A 16-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 21Mar2021 at 15:00 (at the age of 16-years-old), as a single dose for COVID-19 immunisation. The patient had no medical history. Concomitant medications included ethinylestradiol; norgestimate (TRI-LO-SPRINTEC) and biotin supplement (MANUFACTURER UNKNOWN); both on unknown dates for unknown indications. The patient had no allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 04Apr2021, the patient experienced 1.5 inch round raised welt at the injection site. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. The clinical outcome of the event 1.5 inch round raised welt at the injection site was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Eye pain, Headache
Clinical narrative: Left Eye pain; Headache; This is a spontaneous report from a contactable pharmacist. A 54-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the right arm on 03Apr2021 at 11:15 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. Medical history included type 1 diabetes mellitus and allergy to sulfa. Concomitant medications included insulin lispro (HUMALOG) for type 1 diabetes mellitus and acetylsalicylic acid (ASPIRIN) 81 mg daily for an unknown indication, both taken from unknown dates. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Apr2021 at 13:15, within 2 hours of receiving vaccination, the patient experienced headache. On 03Apr2021 around 19:00, the patient experienced left eye pain which was ongoing. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events headache and left eye pain was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Blood glucose, Blood glucose increased
Clinical narrative: Blood sugars were elevated. Average blood sugar readings are 130 and lower. They were running 200-302 for most of the 4 days following the injection.; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 01Apr2021 at 12:30 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Medical history included diabetes (controlled) from an unspecified date. Concomitant medications included metformin (MANUFACTURER UNKNOWN), fluoxetine (MANUFACTURER UNKNOWN) all from an unknown date for an unspecified indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Apr2021 at 17:00 the patient experienced blood sugars were elevated. Average blood sugar readings were 130 and lower. They were running 200-302 (UNITS UNSPECIFIED) for most of the 4 days following the injection. The patient did not receive any treatment for the event. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event Blood sugar increased was recovered on an unspecified date in 2021.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.